vasogen
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
54) TREATMENT OF AUTOIMMUNE DISEASES 4,632,980 12/1986 Zee et al. ................................ 530/380 4,831,268 5/1989 Fisch…
The increasing prevalence of heart failure poses enormous challenges for health care systems worldwide. Despite effective medical…
Background—Atherothrombosis is the underlying cause of cardiovascular, cerebrovascular, and peripheral arterial disease and is…
Administration of VP025 (Vasogen Inc.), a novel drug formulation based on phospholipid nanoparticles incorporating…
Yvonne Nolan, Frank O. Maher||, Darren S. Martin, Rachael M. Clarke, Miriam T. Brady, Anthony E Bolton, Kingston H. G. Mills, and…
We have reported that Vasogen’s immune modulation therapy (IMT), a procedure involving intramuscular administration of autologous…
AIM
Vasogen's immune modulation therapy (IMT)* involves the ex vivo exposure of a sample of autologous blood to 3 oxidative…
OBJECTIVES
this study examined the effect of immune modulation therapy (IMT) on claudication distances.
MATERIALS AND METHODS
a…
Systemic injection of lipopolysaccharide (LPS) blocks the expression of long-term potentiation in the hippocampus of the rat…
Vasogen is developing VasoCare, an immune modulation therapy, as a potential treatment for peripheral vascular disease (PVD) and…